ENTRY       D05706                      Drug
NAME        Raxibacumab (USAN/INN);
            Abthrax (TN);
            Raxibacumab (TN)
PRODUCT     RAXIBACUMAB (Emergent Manufacturing Operations Baltimore LLC)
FORMULA     C6320H9794N1702O1998S42
EXACT_MASS  142844.5367
MOL_WEIGHT  142932.323
REMARK      ATC code: J06BC02
            Product: D05706<US>
EFFICACY    Anti-anthrax, Antitoxin
  DISEASE   Inhalational anthrax [DS:H00328]
  TYPE      Monoclonal antibody
TARGET      protective antigen (PA) [KO:K11030]
  PATHWAY   ko04621(K11030)  NOD-like receptor signaling pathway
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             J ANTIINFECTIVES FOR SYSTEMIC USE
              J06 IMMUNE SERA AND IMMUNOGLOBULINS
               J06B IMMUNOGLOBULINS
                J06BC Antibacterial monoclonal antibodies
                 J06BC02 Raxibacumab
                  D05706  Raxibacumab (USAN/INN) &lt;US&gt;
            Antimicrobials [BR:br08307]
             Antibacterials
              Other antibacterials
               Monoclonal antibody
                D05706  Raxibacumab (USAN/INN) &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D05706
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D05706
DBLINKS     CAS: 565451-13-0
            PubChem: 47207367
///
